Clinical and Translational Oncology

, Volume 15, Issue 12, pp 1018–1024

SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013

Clinical Guides in Oncology

DOI: 10.1007/s12094-013-1096-z

Cite this article as:
Mesía, R., Pastor, M., Grau, J.J. et al. Clin Transl Oncol (2013) 15: 1018. doi:10.1007/s12094-013-1096-z

Abstract

Head and neck cancer represents 5 % of oncologic cases in adults. Early stage treatments are local with surgery and/or radiotherapy. For locally advanced stages, treatment requires radiotherapy combined with platinum-based drugs or cetuximab. Induction chemotherapy should be considered for selected cases. In the case of metastatic disease, adjuvant or palliative treatment is based on platinum agents and cetuximab.

Keywords

Head and neck cancerInduction chemotherapyTPFCetuximabEXTREME ERBITAX

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2013

Authors and Affiliations

  • R. Mesía
    • 1
  • M. Pastor
    • 2
  • J. J. Grau
    • 3
  • E. del Barco
    • 4
  1. 1.Servicio de Oncología MédicaInstitut Català d’Oncologia-L’HopsitaletBarcelonaSpain
  2. 2.Servicio de Oncología MédicaHospital General Universitario La FeValenciaSpain
  3. 3.Servicio de Oncología MédicaHospital Clinic deBarcelonaSpain
  4. 4.Servicio de Oncología MédicaHospital Universitario de SalamancaSalamancaSpain